IGC Pharma vs Longeveron
IGC and LGVN side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How IGC and LGVN compare
Longeveron is the larger company, worth 3.5 times as much as IGC Pharma ($67.3M against $19.4M).
IGC Pharma grew revenue faster over the last twelve months (−15.4% versus −42.7% for Longeveron).
IGC Pharma keeps more of each dollar of sales as profit, with a net margin of −702% compared with −1978% at Longeveron.
Longeveron scores higher on the StockData Score (5 against 2 for IGC Pharma), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | IGC | LGVN |
|---|---|---|
| Size and price | ||
| Market cap | $19.4M | $67.3M |
| Share price | $0.188 | $2.11 |
| Change, 1 year | −47.5% | −69.0% |
| Change, 5 years | −86.2% | −99.9% |
| Beta (5Y) | 0.82 | 1.44 |
| Employees | 67 | 37 |
| StockData Score | ||
| Total score | 2 | 5 (better) |
| Valuation score | 0 | 0 |
| Growth score | 0 | 0 |
| Performance score | 1 (better) | 0 |
| Health score | 1 | 5 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 17.3× (better) | 56.7× |
| P/B | 3.2× (better) | 6.5× |
| FCF yield | – | −30.5% |
| Fair value | $0.158 | – |
| Margin of safety | −18.9% | – |
| Growth | ||
| Revenue growth (TTM) | −15.4% (better) | −42.7% |
| Revenue growth, 5Y average | – | −26.6% |
| Profitability | ||
| Gross margin | 21.9% | 69.8% (better) |
| Operating margin | −987% (better) | −1993% |
| Net margin | −702% (better) | −1978% |
| FCF margin | – | −1730% |
| Return on equity | −129% (better) | −204% |
| Return on invested capital | −150% (better) | −1412% |
| Financial health | ||
| Debt / equity | 0.02 (better) | 0.00 |
| Current ratio | 0.39 | 2.63 (better) |
| Altman Z-score | −19.71 | −9.42 (better) |
| Piotroski F-score | – | 1 |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 5.1% | 1.5% |
| Held by insiders | 13.2% | 43.8% |
| Short interest, % of float | 0.44% | 0.88% |
Go deeper
- IGC stock overview
- IGC income statement
- IGC valuation and score
- LGVN stock overview
- LGVN income statement
- LGVN valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.